ACT Brief: Moving Beyond AI Pilots, FDA Advances Bayesian Trials, and Sites Strained by Trial Design
In today’s ACT Brief, we examine what will separate sponsors that scale AI beyond pilots in 2026, break down the FDA’s new ...
This article is part of the “Defending the Algorithm™” series and was written by Pittsburgh, Pennsylvania Business and IP Trial Lawyer Acacia B. Perko, Esq., with research and drafting assistance from ...
Phase 1a/1b study in 97 patients demonstrates mitochondrial metabolic reprogramming induced by BPM31510-IV and supports advancement in multiple aggressive solid tumor indications. BPM31510-IV has ...
Artificial intelligence can solve problems at remarkable speed, but it's the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists ...
Some 2.5 million people in the U.S. develop a pressure injury, or bedsore, in hospitals every year. Bayesian’s platform uses AI to analyze electronic medical records and identify patients at risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback